IT1312061B1 - Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di - Google Patents

Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di

Info

Publication number
IT1312061B1
IT1312061B1 ITMI990729A IT1312061B1 IT 1312061 B1 IT1312061 B1 IT 1312061B1 IT MI990729 A ITMI990729 A IT MI990729A IT 1312061 B1 IT1312061 B1 IT 1312061B1
Authority
IT
Italy
Prior art keywords
nucleotidal
revelation
hospitals
hiv
participate
Prior art date
Application number
Other languages
English (en)
Inventor
Veljko Veljkovic
Jelena Prljic
Nevena Velikovic
Radmila Metlas
Original Assignee
Diapharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diapharm Ltd filed Critical Diapharm Ltd
Priority to ITMI990729 priority Critical patent/IT1312061B1/it
Priority to EP00107333A priority patent/EP1043407A3/en
Priority to CA 2302898 priority patent/CA2302898A1/en
Publication of ITMI990729A1 publication Critical patent/ITMI990729A1/it
Application granted granted Critical
Publication of IT1312061B1 publication Critical patent/IT1312061B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITMI990729 1999-04-09 1999-04-09 Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di IT1312061B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI990729 IT1312061B1 (it) 1999-04-09 1999-04-09 Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di
EP00107333A EP1043407A3 (en) 1999-04-09 2000-04-04 Nucleotide sequence for detection and characterization of the HIV-1 field isolates participating in the recombination processes directed by the chi sequence
CA 2302898 CA2302898A1 (en) 1999-04-09 2000-04-04 Nucleotide sequence for detection and characterization of the hiv-1 field isolates participating in the recombination processes directed by the chi sequence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI990729 IT1312061B1 (it) 1999-04-09 1999-04-09 Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di

Publications (2)

Publication Number Publication Date
ITMI990729A1 ITMI990729A1 (it) 2000-10-09
IT1312061B1 true IT1312061B1 (it) 2002-04-04

Family

ID=11382643

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI990729 IT1312061B1 (it) 1999-04-09 1999-04-09 Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di

Country Status (3)

Country Link
EP (1) EP1043407A3 (it)
CA (1) CA2302898A1 (it)
IT (1) IT1312061B1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306901B2 (en) 2001-08-08 2007-12-11 Tibotec Pharmaceuticals, Ltd. Methods and means for assessing HIV envelope inhibitor therapy
EP1602736A1 (en) * 2004-06-04 2005-12-07 Bio-Rad Pasteur HIV type and subtype detection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0570493A (ja) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst ヒト免疫不全ウイルス（ｈｉｖ）関連免疫調製物
WO1999022008A1 (fr) * 1997-10-27 1999-05-06 Sumitomo Electric Industries, Ltd. Inducteur pour la production d'un anticorps specifique de l'antigene, vecteur d'expression contenant le gene requis a cette fin, et procede pour induire la production de l'anticorps specifique de l'antigene

Also Published As

Publication number Publication date
EP1043407A3 (en) 2000-10-18
ITMI990729A1 (it) 2000-10-09
CA2302898A1 (en) 2000-10-09
EP1043407A2 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
ATE374204T1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
HK1066466A1 (en) Pharmaceutical formulations of antineoplastic agents in particular temozolomide processes of making and using the same
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
NO20051493D0 (no) Imidazolpyridiner og fremgangsmater for fremstilling og anvendelse av de samme
NO20014524L (no) Rekombinant IL-18 antagonister anvendelige i behandling av IL- 18 medierte forstyrrelser
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
EE200100372A (et) TWEAK-valgu ja TWEAK-valgu retseptori antagonistid ja nende kasutamine immuunhaiguste raviks
AU2003213768A8 (en) Use of benzimidazole analogs in the treatment of cell proliferation
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
NO20034311D0 (no) CCR5-antagonister for behandling av AIDS
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EP1581243A4 (en) ORAL LACTOFERRINE FOR THE TREATMENT OF SEPSIES
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
IT1312061B1 (it) Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di
IT1313700B1 (it) Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa
ITUD990222A0 (it) Apparato per il trattamento di piantagioni in filari
DE69934336D1 (de) Verwendung von halofuginone zur behandlung von urethralstriktur